ACB · Aurora Cannabis Inc · Metrics
$5.24
+0.05 (+0.96%)
At close · Nov 6
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$331.74M
Shares
63.31M
Volume · Nov 6
2.09M
Avg daily vol (3M)
1.47M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
ACB metrics
54 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$5.24
Market cap
$331.74M
Price action
23 metricsPrice change (1W)
+27.2%
Price change (30D)
+16.4%
Price change (3M)
+74.2%
Price change (6M)
+51.3%
Price change (YTD)
+23.0%
Price change (1Y)
+16.4%
Trailing year
Price change (5Y)
—
52-week high
$5.57
52-week low
$2.58
Change from 52-week high
-6.8%
Change from 52-week low
+101.2%
Annualized volatility
60.4%
Annualized volatility (3M)
75.9%
Implied volatility (30D)
36.2%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.1
RSI (14D)
76.4
Price vs SMA 50
+25.9%
Price vs SMA 200
+46.0%
Avg volume (3M)
1.47M
Relative volume
3.5
Average dollar volume
$6.10M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
63.31M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.9
reciprocal yield 111.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-12
Last earnings
2026-08-05
Profitability
9 metricsGross margin
42.6%
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
$180.95M
Operating profit (TTM)
$4.95M
Net income (TTM)
−$150.43M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+11.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-5,450.0%
Shares change YoY
+3.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-40.6%
Return on assets
-21.5%
Debt / equity
—
Current ratio
5.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.6
Interest coverage
2.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$46.36M
Total assets
$430.79M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
155
13F filer change QoQ
-6
Institutional ownership
10.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-7.4%
Holder tenure
11.7
Price vs estimated holder cost
-54.9%
Ownership (registered funds)
1 metricsIndex-fund ownership
2.1%
Short interest
3 metricsShort interest
12.9%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
100 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—